+86-13031714605
info@millionpharm.com

  • Company
    • About us

    • Partners

    • Value

    • Careers

  • Product
    • Pharmaceutical API

    • Advanced Intermediate

  • R&D&Site
  • News&Events
  • Sustainability
  • Contact Us

PRODUCTS


Home > Products > Advanced Intermediates > Apixabn intermediates
  • 91-8;ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate
    91-8;ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate
  • 07-4;ethyl 6-(4-aMinophenyl)-1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate
    07-4;ethyl 6-(4-aMinophenyl)-1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate
  • 91-3;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester
    91-3;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester
  • 44-1;3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one
    44-1;3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one
  • 26-3;1-(4-AMinophenyl)-5,6-dihydro-3-(4-Morpholinyl)-2(1h)-pyridinone
    26-3;1-(4-AMinophenyl)-5,6-dihydro-3-(4-Morpholinyl)-2(1h)-pyridinone
  • 03-0;3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one
    03-0;3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one
  • 29-9;3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one
    29-9;3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one
  • 01-2;3,3-Dichloro-1-(4-nitrophenyl)piperidin-2-one
    01-2;3,3-Dichloro-1-(4-nitrophenyl)piperidin-2-one
  • 07-3; Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate
    07-3; Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate
  • 63-8;Ethyl (2Z)-chloro[(4-methoxyphenyl)hydrazono]ethanoate
    63-8;Ethyl (2Z)-chloro[(4-methoxyphenyl)hydrazono]ethanoate
    • 

      Cerebro-cardiovascular

    • 

      Central nervous system

    • 

      Cancer/tumor

    • 

      Anti-diabetics

    • 

      R&D&Pipeline

    • 

      Other APIS

    • 

      Peptides

    • 

      Supplements

    • 

      Sexual Enhancement

    • 

      Apixabn intermediates

    • 

      Bexagliflozin Intermediate

    • 

      Lurasidon intermediates

    • 

      Vortioxeti intermediates

    • 

      Selpercatinib intermediates

    • 

      Indacater intermediates

    • 

      Elacestrant intermediates

    • 

      Repotrectinib/TPX-0005 intermediate

    • 

      Baricitinib Intermediate

    • 

      Ropsacitinib intermediate

    • 

      Other intermediates

    WELCOME

    +86-13031714605
    info@millionpharm.com
    +86-13031714605

    Products

    • Pharmaceutical API

      • Cerebro-cardiovascular

      • Central nervous system

      • Cancer/tumor

      • Anti-diabetics

      • R&D&Pipeline

      • Other APIS

    • Advanced Intermediates

    • Company

      • About us

      • Partners

      • Value

      • Careers

    • R&D&Site

    • News&Events

    • Sustainability

    Contact Us

    Jinan Million Pharmaceutical Co., Ltd

    (Jinan Milin Pharmaceutical Co., Ltd)

    +86-13031714605 (Wechat)
    +86-13031714605
    +86-531-68659554
    info@millionpharm.com
    Room1-2208, Gaoxin district, Jinan, Shandong
     3299907431

    Attention: All products are only for research

    © million | All Rights Reserved

    Leave A Message

    If you are interested in our products and want to know more details, please leave a message here, we will reply you as soon as we can.

    SUBMIT
    
    
    +86-13031714605
    
    WhatsApp
    
    Email
    
    Inquiry
    